May 8, 2026
Tag: Cancer Therapeutics Research Program
May 7, 2026
Der, Yeh provide scientific context for recent progress in RAS therapeutics for pancreatic cancer
Channing J. Der, PhD, and Jen Jen Yeh, MD, published an editorial contextualizing a landmark clinical study evaluating daraxonrasib, a first-in-class drug targeting KRAS-mutant metastatic pancreatic ductal adenocarcinoma (PDAC).
April 24, 2026
A new clinical trial for metastatic breast cancer opens
A new clinical trial that adjusts treatment as breast cancer evolves is now open and enrolling patients at UNC Lineberger Comprehensive Cancer Center.
April 22, 2026
The News & Observer: New cancer drugs could double survival time. What NC doctors want you to know
April 19, 2026
STAT: The race to catch KRAS, pancreatic cancer’s ‘greasy ball,’ and create the most promising drug in decades
April 17, 2026
UNC Gynecologic Oncology faculty honored at 2026 National SGO Meeting
Victoria Bae-Jump, MD, PhD, was awarded the SGO Legacy of Impact Award in recognition of her sustained research contributions to gynecologic cancer care. Olivia Lara, MD, MS, and Ben Albright, MD, MS, were each awarded research grants.
April 7, 2026
ABC11: Mentors remember former Miss NC Carrie Everett: ‘Our forever queen’
April 7, 2026
WRAL: After former Miss North Carolina’s death, doctor says young cancer diagnoses becoming more common
April 3, 2026
UNC Lineberger and UNC faculty and trainees scheduled to present findings at American Association of Cancer Research Annual Meeting
UNC Lineberger researchers will present findings, chair sessions, lead session discussions and share their perspectives in topical forums and education sessions during the AACR Annual Meeting.
March 27, 2026
UNC researchers publish findings in JAMA Network Open about the impact of diagnostic wait time on ovarian cancer survival
Led by a team of UNC researchers, this study explored the relationship between survival and how quickly patients are diagnosed with ovarian cancer.